The information disclosed in this part of the Astellas Website is provided for better understanding of Astellas by stakeholders including shareholders and investors, but is intended to neither solicit nor recommend the purchase of the Astellas's stock.
(1) Statements made in this part of the Astellas Website with respect to Astellas's current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas. These statements are based on management's current assumptions and beliefs in light of the information currently available to it and involve known and unknown risks and uncertainties. Consequently, undue reliance should not be placed on these statements. Astellas cautions the reader that a number of important factors could cause actual results to differ materially from those discussed in the forward-looking statements.Such factors include, but are not limited to:
- changes in general economic conditions in, and the laws and regulations relating to, Astellas's markets,
- currency exchange rate fluctuations,
- delays in new product launches,
- the inability of Astellas to market existing and new products effectively,
- Astellas's ability to continue research and develop products accepted by customers in highly competitive markets and
- infringements of Astellas's intellectual property rights.
(2) The pages include the information regarding pharmaceuticals including the ones under development, however, they are not intended for advertisement or medical advice at all.
(3) Addition, change or deletion of the information may occur at anytime without notice.